May 15 Northfield Capital Corp
* NORTHFIELD CAPITAL ANNOUNCES NORMAL COURSE ISSUER BID
* CO MAY, FROM MAY 19, 2017 TO MAY 18, 2018, PURCHASE ON TSX VENTURE EXCHANGE UP TO 123,102 CLASS A RESTRICTED VOTING SHARES IN TOTAL Source text for Eikon: Further company coverage:
CORRECTED-Germany's Merck gets EU backing for oral MS drug
FRANKFURT, June 23 Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral multiple sclerosis (MS) drugs in Europe, six years after its first attempt to launch the cladribine pill failed.
WORLD NEWS SCHEDULE AT 1800 GMT/2 PM ET
Iraqi forces free hundreds of civilians in Mosul Old City battles as death toll mounts